Home  Register Now  My Tradeeasy

Jinan Sky-worth Pharmaceutical Group Preview Staging

Erlotinib Hcl (cas:183319-69-9)

Item Code / Model Number:
SK-01

Description:  CAS: 183319-69-9
Appearance Almost white to pale yellow powder Pale yellow powder
Melting Point 228C-230C 228C-230C
Loss on Drying NMT0.5% 0.3%
Related Impurity by HPLC
Total impurity NMT1.5% 0.7%
Single impurity NMT0.3% 0.25%
Assay (HPLC) NLT99.0% 99.3%
In-house standard
Packing:1kg/tin or according to customer request
U.S. FDA approval of its role standard in the treatment of advanced NSCLC invalid the second-tier or third-line treatment. The results showed that part of the programme combined with chemotherapy did not increase the response rate and survival of patients, for head and neck cancer, metastatic renal cell carcinoma, pancreatic cancer, breast cancer, Tarceva with chemotherapy or other targeted therapy drugs such as Avastin and used to good effect show
Email:skyworth_pharma@126.com
Place of Origin: China
Brand: Sk
Port: FOB Qingdao
Packing: 500G TIN
Delivery Time: 20 days
Min Order Quantity: 500G

Company Profile

  • Business Type:
  • Manufacturer
  • Country:
  • China
  • Brands:
  • Sk
  • Principal Customers:
  • Drug Factory
  • Focus Markets:
  • Worldwide
  • Existing Markets:
  • Thailand, Usa
  • Factory Location:
  • Shandong

Contact Information

  • Company Name:
  • Jinan Sky-worth Pharmaceutical Group
  • Country:
  • China
  • Address:
  • Qilu Industrial Zone,Hi-tech Development Area,Jinan City,Shandong Province,China
  • Website:
  • http://skyworthpharma.itrademarket.com
  • Contact Person:
  • Mr. Devin Lee (Manager)
  • Tel:
  • (86) 531-88136969
  • Fax:
  • (86) 531-88136969

Home - Products - Suppliers - Selling Leads - Buying Leads - Registration | Success Stories - Procurement Meetings | Site Map

About Tradeeasy - Contact Us | Buyer Services - Seller Services | Business Links - Link to us | Privacy Policy - Terms of Use 

GlobalMarket Group: GlobalMarket.com - Tradeeasy.com - B2S.com

©1997-2008 Tradeeasy.com. All rights reserved.